124
Participants
Start Date
January 1, 2008
Primary Completion Date
May 25, 2011
Study Completion Date
March 19, 2013
ofatumumab
1000 mL dilution of 35mls ofatumumab in sterile, pyrogen free, 0.9% NaCl
GSK Investigational Site, Copenhagen
GSK Investigational Site, Glostrup Municipality
GSK Investigational Site, Hellerup
GSK Investigational Site, Szombathely
GSK Investigational Site, New York
GSK Investigational Site, Duncansville
GSK Investigational Site, Fort Lauderdale
GSK Investigational Site, Los Angeles
GSK Investigational Site, Warsaw
GSK Investigational Site, Ipswich
Lead Sponsor
GlaxoSmithKline
INDUSTRY